logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Masashi Kondo

fujita health university
H指数:49
被引数:9,258

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High diagnostic yield and treatment impact of bronchoscopy in elderly lung cancer patients (> 80 years): A single-center retrospective study

支气管镜检查在80岁以上老年肺癌患者中的诊断收益和治疗影响：一项单中心回顾性研究

RESPIRATORY INVESTIGATION
IF2
2025-11-010
OAAI
Maeda, Shingo; Ina, Takuma; Ota, Atsuhiko; Matsunaga, Masaaki; Horiguchi, Tomoya; Ikeda, Aki; Moriya, Ryoma; Sato, Takaya; Sawada, Chiaki; Oya, Yuko; Okachi, Shotaro; Goto, Yasuhiro; Isogai, Sumito; Hashimoto, Naozumi; Kondo, Masashi; Imaizumi, Kazuyoshi
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK plus NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials

布加替尼在ALK TKI初治的ALK阳性晚期NSCLC患者中的疗效和安全性：ALTA-1L和J-ALTA试验的整合分析

LUNG CANCER
IF4.4
2025-03-010
PRE
Camidge, D. Ross; Sugawara, Shunichi; Kondo, Masashi; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James C. H.; Hochmair, Maximilian J.; Lee, Ki Hyeong; Delmonte, Angelo; Kudou, Kentarou; Asato, Takayuki; Hupf, Bradley; Vranceanu, Florin; Fram, Robert J.; Ohe, Yuichiro; Popat, Sanjay
Comparing subcutaneous vs intravenous amivantamab with lazertinib in EGFR-mutated advanced NSCLC: Analysis of Asian patients from PALOMA-3

比较皮下注射与静脉注射阿曼曲单抗联合拉泽替尼在EGFR突变晚期NSCLC中的疗效：PALOMA-3研究中亚洲患者分析

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Lee, S-H.; Akamatsu, H.; Yang, J. C-H.; Lim, S. M.; Liu, B.; John, T.; Wang, J.; Ohe, Y.; Kondo, M.; Tamiya, M.; Danchaivijitr, P.; Hsu, P-C.; Zhuo, J.; Saadoun, C.; Saxena, N.; Balaburski, G.; Ribeiro, L.; Gamil, M.; Baig, M.; Cheng, Y.
How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand-Alone Trials? A Comprehensive Simulation Study for Streamlining Drug Development During a Pandemic

自适应平台试验比多个独立试验效率高多少？在大流行期间简化药物开发的综合模拟研究

CLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
2024-03-051
PRE
Sasaki, Masanao; Sato, Hiroyuki; Uemura, Yukari; Mikami, Ayako; Ichihara, Nao; Fujitani, Shigeki; Kondo, Masashi; Doi, Yohei; Morino, Eriko; Tokita, Daisuke; Ohmagari, Norio; Sugiura, Wataru; Hirakawa, Akihiro
A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2

针对SARS-CoV-2的皮内，可控的自我复制核糖核酸疫苗EXG-5003的I/II期临床试验

VACCINES
IF3.4
2023-11-274
OAAI
Koseki, Takenao; Teramachi, Mayumi; Koga, Minako; Ko, Minoru S. H.; Amano, Tomokazu; Yu, Hong; Amano, Misa; Leyder, Erica; Badiola, Maria; Ray, Priyanka; Kim, Jiyoung; Ko, Akihiro C.; Achour, Achouak; Weng, Nan-ping; Imai, Takumi; Yoshida, Hisako; Taniuchi, Satsuki; Shintani, Ayumi; Fujigaki, Hidetsugu; Kondo, Masashi; Doi, Yohei
Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment
CLINICAL LUNG CANCER
IF3.3
2022-11-011
OAAI
Yoneshima, Yasuto; Morita, Satoshi; Ando, Masahiko; Nakamura, Atsushi; Iwasawa, Shunichiro; Yoshioka, Hiroshige; Goto, Yasuhiro; Takeshita, Masafumi; Harada, Toshiyuki; Hirano, Katsuya; Oguri, Tetsuya; Kondo, Masashi; Miura, Satoru; Hosomi, Yukio; Kato, Terufumi; Kubo, Toshio; Kishimoto, Junji; Yamamoto, Nobuyuki; Nakanishi, Yoichi; Okamoto, Isamu

研究方向

暂未获取到该数据
Y
Yoshinori Hasegawa
H 指数:63论文数:625被引数:1.5万
K
Kaoru Shimokata
H 指数:58论文数:528被引数:1.4万
K
Kazuyoshi Imaizumi
H 指数:36论文数:345被引数:4,709
H
Hiroaki Kume
H 指数:34论文数:235被引数:4,017
Y
Yoshitaka Sekido
H 指数:78论文数:432被引数:1.9万
Y
Yasuhiro Gotô
H 指数:31论文数:334被引数:3,789
S
Satoru Ito
H 指数:39论文数:213被引数:4,698
J
John D. Minna
H 指数:174论文数:2,276被引数:11.4万
M
Mitsuo Sato
H 指数:48论文数:527被引数:1.1万
T
Tetsunari Hase
H 指数:28论文数:168被引数:2,443